CareConekta:改善南非产后HIV护理参与度的移动健康干预随机对照试验研究方案
该研究方案旨在开发和测试智能手机应用CareConekta,通过定位功能描述围产期妇女的流动性,并评估该应用结合短信通知、电话和/或WhatsApp消息对HIV护理参与度的可行性、可接受性和初步疗效。研究将在南非开普敦Gugulethu助产士产科单位招募200名符合条件的HIV感染孕妇。
要点
- CareConekta应用通过智能手机定位前瞻性描述围产期妇女的流动性。
- 干预包括应用加短信通知、电话和/或WhatsApp消息以促进HIV护理参与。
- 研究将评估干预的可行性、可接受性和初步疗效,并描述流动性对护理参与的影响。
核心结论
- 该研究将提供围产期流动性及其对HIV护理参与影响的关键信息,并试点测试改善护理参与的干预措施。
研究设计与样本
- 研究为为期3年的项目,计划在南非开普敦Gugulethu助产士产科单位招募200名符合条件的HIV感染孕妇。
- 研究包括两个目标:评估CareConekta干预的可行性、可接受性和初步疗效;描述围产期流动性及其对HIV护理参与的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: South Africa is home to the world's largest antiretroviral therapy program but sustaining engagement along the HIV care continuum has proven challenging in the country and throughout the wider region. Population mobility is common in South Africa, but there are important research gaps in describing this mobility and its impact on engagement in HIV care. Postpartum women and their infants in South Africa are known to be at high risk of dropping out of HIV care after delivery and are frequently mobile. METHODS: In 2017, we developed a beta version of a smartphone application (app) - CareConekta - that detects a user's smartphone location to allow for prospective characterization of mobility. Now we will adapt and test CareConekta to conduct essential formative work on mobility and evaluate an intervention - the CareConekta app plus text notifications and phone calls and/or WhatsApp messages - to facilitate engagement in HIV care during times of mobility. During the 3-year project period, our first objective is to evaluate the feasibility, acceptability, and initial efficacy of using CareConekta as an intervention to improve engagement in HIV care. Our second objective is to characterize mobility among South African women during the peripartum period and its impact on engagement in HIV care. We will enroll 200 eligible pregnant women living with HIV and receiving care at the Gugulethu Midwife Obstetric Unit in Cape Town, South Africa. DISCUSSION: This work will provide critical information about mobility during the peripartum period and the impact on engagement in HIV care. Simultaneously, we will pilot test an intervention to improve engagement with rigorously assessed outcomes. If successful, CareConekta offers tremendous potential as a research and service tool that can be adapted and evaluated in multiple geographic regions, study contexts, and patient populations. TRIAL REGISTRATION: ClinicalTrials.gov: NCT03836625. Registered on 8 February 2019.
引用
- Clouse K, Phillips TK, Camlin C, et al. CareConekta: study protocol for a randomized controlled trial of a mobile health intervention to improve engagement in postpartum HIV care in South Africa. Trials. 2020. PMID: 32164771. doi:10.1186/s13063-020-4190-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。